Kda Group Inc(KDA-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.075
Day High0.075
Open:0.075
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Newswire.ca
AN INDEPENDENT EVALUATION CONFIRMS THE CLINICAL AND ORGANIZATIONAL BENEFITS OF THE MEDHERIZE PLATFORM IN BREAST ONCOLOGY
Newswire.ca
KDA GROUP COMPLETES DEBT SETTLEMENT
Newswire.ca
KDA GROUP ANNOUNCES RESULTS OF SHAREHOLDERS' ANNUAL GENERAL MEETING AND THE SETTLEMENT OF JUDICIAL CLAIMS
Newswire.ca
KDA GROUP ANNOUNCES THE APPOINTMENT OF MARTIN KIROUAC AS CHIEF TECHNOLOGY OFFICER OF ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA
Newsfile
Upcoming Meeting Dates - March 30, 2026
Newswire.ca
KDA GROUP ANNOUNCES THE ACQUISITION OF THE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.
Newsfile
Upcoming Meeting Dates - March 16, 2026
Newswire.ca
KDA ANNOUNCES THE APPOINTMENT OF A NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER
Newswire.ca
UPDATE OF THE TRANSACTION ANNOUNCED ON NOVEMBER 25, 2025, FOR THE ACQUISITION OF THE MINORITY INTEREST IN THE SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.
Newswire.ca
KDA GROUP ANNOUNCES A COLLABORATION TO INTEGRATE NEW CLINICAL ALERTS INTO THE MEDHERIZE PLATFORM TO SUPPORT THE ADOPTION OF NEXT-GENERATION SEQUENCING FOR BREAST CANCER PATIENTS
Newswire.ca
KDA GROUP ANNOUNCES PARTNERSHIP AGREEMENT WITH CHU DE QUÉBEC-UNIVERSITÉ LAVAL FOR THE DEPLOYMENT OF MEDHERIZE
Newswire.ca
KDA GROUP DEPLOYS MEDHERIZE ACROSS COMMUNITY PHARMACIES: A MAJOR STEP FORWARD IN THE MANAGEMENT OF ORAL ANTICANCER THERAPIES
Newswire.ca
KDA GROUP ANNOUNCES AGREEMENT TO ACQUIRE MINORITY INTEREST IN ITS SUBSIDIARY GROUPE TECHNOLOGIQUE KDA INC.
Newswire.ca
KDA GROUP OPENS A U.S. SUBSIDIARY AND ACCELERATES THE GROWTH OF ITS MEDHERIZE SOLUTION
PR Newswire
KDA GROUP ANNOUNCES CLOSING OF PRIVATE PLACEMENT
Newswire.ca
KDA GROUP RECEIVES DSQ CERTIFICATION FOR ADHERIZE+ PLATFORM -- MEDHERIZE MODULE ENTERS CLINICAL DEPLOYMENT PHASE
AI-generated - The Globe and Mail
KDA Gr: Top 10 Undervalued Healthcare Providers & Services Industry Stocks (KDA)
PR Newswire
KDA GROUP REACHES FINAL CERTIFICATION PHASE FOR MEDHERIZE WITH DSQ - DOSSIER SANTÉ QUÉBEC
AI-generated - The Globe and Mail
KDA Gr: Top 10 Undervalued Healthcare Providers & Services Industry Stocks (KDA)

Profile

KDA Group Inc provides technological and operational efficiency solutions for general and specialized health sectors through its technology platform, which includes electronic prescription platforms for Canada and the United States and Adherize and Medherize functionalities for pharmaceutical adherence and oncology-focused therapeutic monitoring. The company operates through two segments: Pharmaceutical Technology and Corporate.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.